Interplay between CARD9 genetic variants and fungal colonization patterns among patients with diabetes

Aiah M Khateb1,2,3, Rahaf Ghazi Alharbi4, Lujain Alsweed5

  • 1Department of Clinical Laboratory Sciences, College of Applied Medical Science, Taibah University, Madina, Saudi Arabia.

Abstract

Insights

Common Caspase Recruitment Domain-containing protein 9 (CARD9) variants are a frequent genetic predisposition for fungal infections in adults with diabetes. Obesity is also a key factor, suggesting a precision medicine approach for risk stratification.

Area of Science:

  • Immunology
  • Genetics
  • Mycology

Background:

  • Diabetes mellitus increases susceptibility to fungal infections.
  • The genetic basis for this vulnerability in Middle Eastern populations is not well understood.
  • Caspase recruitment domain-containing protein 9 (CARD9) is crucial for fungal sensing, but its role in adult diabetic populations is understudied.

Purpose of the Study:

  • To investigate the prevalence of fungal colonization in diabetic individuals.
  • To identify common CARD9 gene variants associated with fungal burden in this population.
  • To explore the interplay between genetic predisposition and metabolic factors in fungal susceptibility.

Main Methods:

  • Screening 107 diabetic participants for fungal colonization.
  • Targeted sequencing of the CARD9 gene.
  • Bioinformatic analysis including heterozygous peak calling and variant annotation.
  • Functional impact prediction using SIFT, PolyPhen-2, and structural modeling.

Main Results:

  • Fungal colonization was common, with Aspergillus niger complex identified frequently.
  • The CARD9 N-terminal CARD domain was a mutational hotspot, with high prevalence of damaging homozygous variants (52.7%).
  • Obesity, not CARD9 variants, emerged as the primary independent predictor of fungal burden, presenting a paradox of stability.

Conclusions:

  • Diabetic populations exhibit a widespread, unrecognized deficiency in the Dectin-1/CARD9 signaling pathway.
  • CARD9 variants represent a common genetic predisposition to fungal infections in adults with diabetes, challenging the view of it as a rare pediatric disease.
  • Integrating CARD9 genotyping with metabolic profiling may enable precision medicine for early antifungal prophylaxis in at-risk patients.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...